← Leaderboards
Anath Shalev
University Of Wisconsin-Madison
$8,832,736
Attributed
$9,465,215
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,498,499 · 7
By mechanism
R01$5,649,176 · 2
U01$2,162,549 · 1
UC4$1,100,265 · 1
U19$1,033,284 · 1
R21$447,300 · 1
P30$105,925 · 1
Top collaborators
- Kirk Michael Habegger2 shared
- Nathaniel Bernard Erdmann1 shared
- W Timothy Garvey1 shared
- Paul A. Goepfert1 shared
- James O Hill1 shared
- Frances E. Lund1 shared
- Troy D Randall1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Ke Li$2,518,424
- Robert Daniel Blank$1,550,750
- Emily A Stevens$94,146
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusApoptosisIn VivoGlucoseBaseStreptozocinMolecularIsletInsulinInhibitor/AntagonistStructure Of Beta Cell Of IsletBeta CellProductionRegulationProtein ExpressionInsightProtein DeficiencyDiabetic MouseNovel StrategiesObesityMediatingAffectDoseMicrornas
Grant awards (30)
TARGETING MASH WITH NOVEL SMALL MOLECULE TXNIP INHIBITOR$635,709
R01 · FY2025 · DK · contact PI
TARGETING MASH WITH NOVEL SMALL MOLECULE TXNIP INHIBITOR$629,249
R01 · FY2024 · DK · contact PI
Tissue and organ specific human B cell immunity: Supplement - Metabolic Risk Factors and Inflammation in PASC Development$1,033,284
U19 · FY2022 · AI
The University of Alabama at Birmingham Diabetes Research Center's Enrichment Program$21,185
P30 · FY2022 · DK · contact PI
Development of an early diagnostic biomarker and novel treatment strategy for T1D$537,606
U01 · FY2021 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$371,250
R01 · FY2021 · DK · contact PI
The University of Alabama at Birmingham Diabetes Research Center's Enrichment Program$21,185
P30 · FY2021 · DK · contact PI
Development of an early diagnostic biomarker and novel treatment strategy for T1D$537,606
U01 · FY2020 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$371,250
R01 · FY2020 · DK · contact PI
The University of Alabama at Birmingham Diabetes Research Center's Enrichment Program$21,185
P30 · FY2020 · DK · contact PI
Development of an early diagnostic biomarker and novel treatment strategy for T1D$537,606
U01 · FY2019 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$371,250
R01 · FY2019 · DK · contact PI
The University of Alabama at Birmingham Diabetes Research Center's Enrichment Program$21,185
P30 · FY2019 · DK · contact PI
Development of an early diagnostic biomarker and novel treatment strategy for T1D$549,731
U01 · FY2018 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$371,250
R01 · FY2018 · DK · contact PI
The University of Alabama at Birmingham Diabetes Research Center's Enrichment Program$21,185
P30 · FY2018 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$371,250
R01 · FY2017 · DK · contact PI
TXNIP Regulation of Endogenous Beta Cell Mass$319,725
R01 · FY2016 · DK · contact PI
TXNIP Regulation of Endogenous Beta Cell Mass$319,725
R01 · FY2015 · DK · contact PI
Targeting TXNIP to enhance beta cell mass in T1D$1,100,265
UC4 · FY2014 · DK · contact PI
TXNIP Regulation of Endogenous Beta Cell Mass$319,725
R01 · FY2014 · DK · contact PI
TXNIP Regulation of Endogenous Beta Cell Mass$319,453
R01 · FY2013 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$246,985
R01 · FY2012 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$246,985
R01 · FY2011 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$251,370
R01 · FY2010 · DK · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$252,000
R01 · FY2009 · DK · contact PI
TXNIP: A NOVEL APPROACH TO PREVENT DIABETIC CARDIOMYOPATHY AND HEART FAILURE$100,800
R21 · FY2009 · HL · contact PI
TXNIP REGULATION OF ENDOGENOUS BETA CELL MASS$252,000
R01 · FY2008 · DK · contact PI
TXNIP: A NOVEL APPROACH TO PREVENT DIABETIC CARDIOMYOPATHY AND HEART FAILURE$157,500
R21 · FY2008 · HL · contact PI
TXNIP: A NOVEL APPROACH TO PREVENT DIABETIC CARDIOMYOPATHY AND HEART FAILURE$189,000
R21 · FY2007 · HL · contact PI